We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Alpha-synuclein phosphoserine 129 (SNCA-pS129) antibody
α-synuclein, Alpha-synuclein phosphoserine 129, SCNA pS129
Non-A beta component of AD amyloid
Non-A4 component of amyloid precursor, NACP
Gene name : SNCA, NACP, PARK1
Non-A beta component of AD amyloid
Non-A4 component of amyloid precursor, NACP
Gene name : SNCA, NACP, PARK1
As low as
$485.80
In stock
Ref
00013574
May be involved in the regulation of dopamine release and transport. Induces fibrillization of microtubule-associated protein tau. Reduces neuronal responsiveness to various apoptotic stimuli, leading to a decreased caspase-3 activation.
| ID Covalab | pab0829-P |
|---|---|
| Product type | Primary antibodies |
| Clonality | Polyclonal antibody |
| Raised in | Rabbit |
| Immunogen | Synthetic peptide derived from C-ter domain of human Alpha-synuclein containing a phosphoserine at position 129. |
| Activity cross reaction | Reacts with human Alpha-synuclein pS129. Cross-reacts with rat, mouse and other species due to sequence homology. |
| Species | Hu, Ms, Rat |
| Labelling | None |
| Form | Purified (protein A) |
| Preservative | None |
| Storage instructions | Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt. |
| Target | Alpha-synuclein phosphoserine 129 (SCNA pS129) |
| Uniprot ID | P37840 |
| Gene ID | 6622 |
| Applications | ELISA, IF, WB |
| Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only : IF (1:50 - 1:500) WB (1:200 - 1:1000) |
Write Your Own Review